S. Badve

发表

G. Wong, E. Au, S. Badve, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cardio-Renal Cascade in hypertensive patients

S. Badve, B. Shah, 2008 .

The Relationship Between Body Mass Index and Organism-Specific Peritonitis

David W. Johnson, K. Sud, C. Hawley, 2018, Peritoneal Dialysis International.

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

David W. Johnson, G. Guyatt, M. Tonelli, 2021, BMJ.

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.

David W. Johnson, M. Tonelli, J. Craig, 2016, JAMA.

Interventions for erythropoietin-resistant anaemia in dialysis patients.

David W. Johnson, E. Beller, V. Perkovic, 2013, The Cochrane database of systematic reviews.

Is the problem with the vehicle or the destination? Does high‐dose ESA or high haemoglobin contribute to poor outcomes in CKD?

David W. Johnson, C. Hawley, S. Badve, 2011, Nephrology.

Expression of Invariant Chain (CD 74) and Major Histocompatibility Complex (MHC) Class II Antigens in the Human Fetus1

Charuhas Deshpande, Sunil Badve, C. Deshpande, 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

An Antigen Reacting with Das-1 Monoclonal Antibody Is Ontogenically Regulated in Diverse Organs Including Liver and Indicates Sharing of Developmental Mechanisms Among Cell Lineages

Sanjeev Gupta, S. Badve, S. Sigal, 2000, Pathobiology.

Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis

G. Hillis, M. Jardine, V. Perkovic, 2016, British Medical Journal.

End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.

David W. Johnson, A. Mallett, C. Hawley, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases

David W. Johnson, C. Hawley, Wen Tang, 2012, BMC Nephrology.

Recent evidence for direct oral anticoagulants in chronic kidney disease

S. Badve, M. Jun, Jeffrey Ha, 2019, Current opinion in nephrology and hypertension.

Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network

David W. Johnson, V. Perkovic, A. Cass, 2013, Kidney international.

Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry

David W. Johnson, A. Webster, K. Sud, 2020, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Biocompatible dialysis fluids for peritoneal dialysis.

David W. Johnson, J. Craig, G. Strippoli, 2014, The Cochrane database of systematic reviews.

Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.

David W. Johnson, J. Craig, G. Strippoli, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial

A. Tonkin, P. Snelling, C. Hawley, 2017, Kidney and Blood Pressure Research.

Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials.

David W. Johnson, C. Hawley, S. Palmer, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis

S. Palmer, G. Strippoli, S. Badve, 2022, Journal of Nephrology.

Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis

A. Bello, V. Jha, M. Jardine, 2022, Clinical kidney journal.

Biocompatible dialysis fluids for peritoneal dialysis.

David W. Johnson, J. Craig, G. Strippoli, 2018, The Cochrane database of systematic reviews.

A nephrology guide to reading and using systematic reviews of randomized trials.

David W. Johnson, S. Palmer, G. Strippoli, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long‐term outcomes of end‐stage kidney disease for patients with IgA nephropathy: A multi‐centre registry study

David W. Johnson, K. Polkinghorne, C. Hawley, 2016, Nephrology.

Challenges of conducting a trial of uric-acid-lowering therapy in CKD

David W. Johnson, V. Perkovic, G. Rangan, 2011, Nature Reviews Nephrology.

Effects of Allopurinol on the Progression of Chronic Kidney Disease.

David W. Johnson, R. Day, V. Perkovic, 2020, The New England journal of medicine.

Subjective global assessment of nutritional status of patients with chronic renal insufficiency and end stage renal disease on dialysis.

S. Badve, H. Vora, Z. Patel, 2006, The Journal of the Association of Physicians of India.

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial

David W. Johnson, K. Polkinghorne, P. Kerr, 2019, PloS one.

Fish oil and aspirin effects on arteriovenous fistula function Omega-3 Fatty Acids Fish Oils

K. Polkinghorne, A. Cass, C. Hawley, 2019 .

Baseline characteristics of the omega‐3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study

K. Polkinghorne, P. Kerr, A. Cass, 2016, Nephrology.

The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications

K. Polkinghorne, P. Kerr, A. Cass, 2015, BMC Nephrology.

Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease

David W. Johnson, S. Badve, S. Hultin, 2021, Current opinion in nephrology and hypertension.

Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial

C. Hawley, S. Badve, N. Toussaint, 2020, American Journal of Nephrology.

Phosphate Balance on Peritoneal Dialysis

S. Badve, B. McCormick, 2008 .

A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).

Edward R. Smith, David W. Johnson, M. Jardine, 2020, Journal of the American Society of Nephrology : JASN.

Recent peritonitis associates with mortality among patients treated with peritoneal dialysis.

David W. Johnson, C. Hawley, S. McDonald, 2012, Journal of the American Society of Nephrology : JASN.

Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.

David W. Johnson, C. Hawley, S. McDonald, 2010, Nephrology, Dialysis and Transplantation.

Daily home hemodialysis: balancing cardiovascular benefits with infectious harms.

David W. Johnson, S. Badve, A. Nadeau-Fredette, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The rationale and design of the Beta‐blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

A. Garg, A. Tonkin, H. Krum, 2015, Nephrology.

Expression of Das-1 in Primary Lung Adenocarcinomas Represents Reactivation of an Oncofetal Pulmonary Antigen

C. Deshpande, A. Yeldandi, S. Badve, 2002, Pathobiology.

Representativeness of Honeypot Trial Participants to Australasian PD Patients

David W. Johnson, E. Beller, A. Cass, 2017, Peritoneal Dialysis International.

International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival

J. Perl, R. Mehrotra, A. Wang, 2022, Kidney360.

Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease.

E. Milanzi, K. Campbell, S. Badve, 2021, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease.

C. Hawley, K. Campbell, S. Badve, 2020, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Representativeness of the PDOPPS cohort compared to the Australian PD population

David W. Johnson, P. Kerr, E. Milanzi, 2021, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis.

David W. Johnson, K. Sud, C. Hawley, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region

David W. Johnson, V. Jha, C. Hawley, 2021, Nephrology.

Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.

David W. Johnson, K. Polkinghorne, C. Hawley, 2016, Kidney international.

Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies.

David W. Johnson, K. Sud, S. Ullah, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients.

David W. Johnson, J. Craig, G. Strippoli, 2013, Kidney international.

Outcomes of Corynebacterium Peritonitis: A Multicenter Registry Analysis

David W. Johnson, K. Sud, C. Hawley, 2017, Peritoneal Dialysis International.

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis.

David W. Johnson, C. Hawley, S. McDonald, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study

David W. Johnson, C. Hawley, S. McDonald, 2012, BMC Nephrology.

Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study.

David W. Johnson, C. Hawley, S. McDonald, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study.

David W. Johnson, C. Hawley, S. McDonald, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes.

David W. Johnson, C. Hawley, S. McDonald, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes

David W. Johnson, C. Hawley, S. Badve, 2012, International journal of nephrology.

Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients

David W. Johnson, K. Sud, C. Hawley, 2017, Peritoneal Dialysis International.

Duration of Hemodialysis Following Peritoneal Dialysis Cessation in Australia and New Zealand: Proposal for a Standardized Definition of Technique Failure

David W. Johnson, K. Sud, S. McDonald, 2016, Peritoneal Dialysis International.

The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial

David W. Johnson, E. Beller, A. Cass, 2015, Peritoneal Dialysis International.

The Role of Monitoring Vancomycin Levels in Patients with Peritoneal Dialysis-Associated Peritonitis

David W. Johnson, C. Hawley, Wen Tang, 2015, Peritoneal Dialysis International.

Socio-Economic Status and Peritonitis in Australian Non-Indigenous Peritoneal Dialysis Patients

David W. Johnson, C. Hawley, Wen Tang, 2015, Peritoneal Dialysis International.

The association between peritoneal dialysis modality and peritonitis.

David W. Johnson, K. Sud, S. McDonald, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Effects of Climatic Region on Peritonitis Risk, Microbiology, Treatment, and Outcomes: a Multicenter Registry Study

David W. Johnson, C. Hawley, S. McDonald, 2013, Peritoneal Dialysis International.

Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study.

David W. Johnson, C. Hawley, S. McDonald, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Bone formation is not coupled to bone resorption in site‐specific manner in adult rats

S. Badve, J. Chow, T. Chambers, 1993, The Anatomical record.

A comparison of microanatomic basis for coupling between bone formation and bone resorption in man and the rat.

S. Badve, J. Chow, T. Chambers, 1993, Bone.

The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program

K. Mahaffey, A. Rodgers, V. Perkovic, 2019 .

Stage-specific regulation of adhesion molecule expression segregates epithelial stem/progenitor cells in fetal and adult human livers

Sanjeev Gupta, S. Badve, D. Benten, 2008, Hepatology international.

Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease

David W. Johnson, S. Badve, A. Tiku, 2021, Current opinion in nephrology and hypertension.

Novel Insights on Chronic Kidney Disease , Acute Kidney Injury and Polycystic Kidney Disease

David W. Johnson, S. Badve, Roshini Malasingam, 2017 .

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

David W. Johnson, V. Perkovic, A. Cass, 2015, Canadian journal of kidney health and disease.

Association Between Haemoglobin Variability and Clinical Outcomes in Chronic Kidney Disease

David W. Johnson, S. Badve, Roshini Malasingam, 2012 .

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

David W. Johnson, V. Perkovic, A. Cass, 2016, Redox report : communications in free radical research.

Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

David W. Johnson, V. Perkovic, A. Cass, 2017, Nephrology.

PUBLISHED VERSION

K. Polkinghorne, D. Pisaniello, A. Hansen, 2015 .

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis

C. Cannon, K. Mahaffey, V. Perkovic, 2022, Diabetes, obesity & metabolism.

Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis.

J. Lv, Z. Wang, S. Badve, 2020, Clinical journal of the American Society of Nephrology : CJASN.

End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases

David W. Johnson, A. Mallett, C. Hawley, 2015, American Journal of Nephrology.

Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.

David W. Johnson, K. Sud, K. Polkinghorne, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, K. Sud, D. Harris, 2020, Nutrients.

The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial.

A. Garg, A. Tonkin, H. Krum, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Dual Inhibition of Gastrointestinal Phosphate Absorption: More Questions Than Answers.

S. Badve, N. Toussaint, W. Yeung, 2019, Journal of the American Society of Nephrology : JASN.

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease.

David W. Johnson, C. Hawley, Wen Tang, 2013, Kidney international.

Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID)

A. Teixeira-Pinto, M. Jardine, J. Craig, 2022, BMC Nephrology.

Chronic kidney disease: Haemodialysis catheter care in practice

David W. Johnson, S. Badve, 2014, Nature Reviews Nephrology.

Does Sevelamer reduce mortality by slowing of progression of coronary calcification?

P. Magner, S. Badve, 2007, Kidney international.

Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients

David W. Johnson, C. Hawley, S. Badve, 2009, NDT plus.

Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.

David W. Johnson, K. Sud, C. Hawley, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

APPETITE PREDICTS INTAKE AND NUTRITIONAL STATUS IN PATIENTS RECEIVING PERITONEAL DIALYSIS.

David W. Johnson, K. Campbell, S. Badve, 2016, Journal of renal care.

Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.

G. Knoll, K. Burns, S. Badve, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Acute renal tubular injury with acute hepatitis A infection: Is it just a coincidence?

S. Badve, D. Desai, P. Abraham, 2004, Nephrology.

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.

David W. Johnson, C. Hawley, Wen Tang, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Bone formation is not coupled to bone resorption in a site-specific manner in adult rats.

S. Badve, J. Chow, T. Chambers, 1992, The Anatomical record.

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.

David W. Johnson, C. Hawley, S. McDonald, 2011, Clinical journal of the American Society of Nephrology : CJASN.

A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes

David W. Johnson, K. Campbell, S. Badve, 2020, Kidney international reports.

The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes

M. Jardine, V. Perkovic, S. Badve, 2020, Diabetes, obesity & metabolism.

The HONEYPOT Randomized Controlled Trial Statistical Analysis Plan

David W. Johnson, E. Beller, A. Cass, 2013, Peritoneal Dialysis International.

Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk

V. Perkovic, C. Hawley, S. Badve, 2012, Nephrology.

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

V. Perkovic, A. Cass, S. Zoungas, 2020, The Cochrane database of systematic reviews.

Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function.

David W. Johnson, C. Hawley, S. McDonald, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Role of Monitoring Gentamicin Levels in Patients with Gram-Negative Peritoneal Dialysis-Associated Peritonitis

David W. Johnson, C. Hawley, Wen Tang, 2014, Peritoneal Dialysis International.

Predictive Biomarkers in Oncology

S. Badve, G. L. Kumar, 2019, Springer International Publishing.

Lack of Expression of the Epstein-Barr Virus (EBV) Gene Products, EBERs, EBNA1, LMP1, and LMP2A, in Breast Cancer Cells

R. Longnecker, C. Deshpande, S. Badve, 2002, Laboratory Investigation.

Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice.

V. Perkovic, P. Kerr, S. Badve, 2022, Heart, lung & circulation.

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

V. Perkovic, A. Cass, S. Zoungas, 2015, The Cochrane database of systematic reviews.

Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease

David W. Johnson, A. Garg, V. Jha, 2019, Annals of Internal Medicine.

Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD

David W. Johnson, C. Hawley, S. Badve, 2021, Journal of the American Society of Nephrology : JASN.

Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial

K. Polkinghorne, P. Kerr, A. Cass, 2017, JAMA internal medicine.

Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.

A. Garg, E. McArthur, Z. Harel, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.

A. Garg, A. Tonkin, H. Krum, 2011, Journal of the American College of Cardiology.

Automated and continuous ambulatory peritoneal dialysis have similar outcomes.

C. Hawley, D. Johnson, S. McDonald, 2008, Kidney international.

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.

V. Perkovic, A. Cass, R. Walker, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Trustworthy Explainability Acceptance: A New Metric to Measure the Trustworthiness of Interpretable AI Medical Diagnostic Systems

Arjan Durresi, Suleyman Uslu, Davinder Kaur, 2021, Computational Intelligence in Security for Information Systems.

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.

David W. Johnson, C. Hawley, S. McDonald, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery

A. Chou, S. Badve, Shir-Jing Ho, 2020, Canadian journal of kidney health and disease.

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.

David W. Johnson, V. Perkovic, D. Harris, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Glucose lowering therapies for chronic kidney disease and kidney transplantation

V. Perkovic, A. Cass, S. Zoungas, 2012 .

The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.

David W. Johnson, C. Hawley, Wen Tang, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.

David W. Johnson, E. Beller, A. Cass, 2014, The Lancet. Infectious diseases.

Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS

David W. Johnson, H. Morgenstern, J. Perl, 2020, Kidney international reports.

Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients

David W. Johnson, K. Sud, C. Hawley, 2020, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD

G. Remuzzi, C. Wanner, J. Lewis, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?

M. Wong, S. Badve, H. Heerspink, 2022, Nephrology.

A Randomized Controlled Trial of Intravenous or Oral Iron for Posttransplant Anemia in Kidney Transplantation

David W. Johnson, C. Hawley, S. Badve, 2012, Transplantation.

Challenges in blood pressure measurement in patients treated with maintenance hemodialysis.

A. Garg, A. Tonkin, A. Cass, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Association between Body Mass Index and Mortality in Incident Dialysis Patients

David W. Johnson, K. Klein, K. Polkinghorne, 2014, PloS one.

Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.

David W. Johnson, K. Polkinghorne, C. Hawley, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial

David W. Johnson, V. Perkovic, A. Cass, 2014 .

Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?

David W. Johnson, S. Badve, A. Tiku, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Superficial temporal artery pseudoaneurysm: diagnosis and preoperative planning with CT angiography.

M. Walker, S. Badve, H. Batjer, 2003, AJNR. American journal of neuroradiology.

Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.

David W. Johnson, C. Hawley, G. Wong, 2016, Clinical journal of the American Society of Nephrology : CJASN.

The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.

David W. Johnson, A. Teixeira-Pinto, J. Craig, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of fish oil and aspirin on arteriovenous fistula failure in haemodialysis - a randomized controlled trial

K. Polkinghorne, P. Kerr, A. Cass, 2016 .

Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, Marie E. Edwards, Adriana V. Gregory, 2021, NEJM Evidence.

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

David W. Johnson, Marie E. Edwards, B. Erickson, 2018, BMJ Open.

The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation

A. Garg, E. McArthur, Z. Harel, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

A. Garg, N. Tangri, O. Djurdjev, 2023, Kidney medicine.

Kidney function and the comparative effectiveness and safety of direct oral anticoagulants versus warfarin in adults with atrial fibrillation: a multicenter observational study.

A. Garg, N. Tangri, O. Djurdjev, 2022, European heart journal. Quality of care & clinical outcomes.

Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer – a population cohort study

G. Wong, S. Badve, W. Lim, 2017, Oncotarget.

PrescribedWater Intake in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, Marie E. Edwards, Adriana V. Gregory, 2021 .

Pathology Elsewhere

S. Badve, 2005, Laboratory Investigation.

Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease

K. Sud, M. Howell, G. Rangan, 2023, Kidney medicine.

Center-Specific Factors Associated with Peritonitis Risk—A Multi-Center Registry Analysis

David W. Johnson, K. Sud, C. Hawley, 2016, Peritoneal Dialysis International.

Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial

M. Woodward, V. Perkovic, N. Poulter, 2021, Diabetes, obesity & metabolism.

Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis.

S. Palmer, G. Strippoli, S. Badve, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Tissue Microarray – Construction and Quality Assurance Part II : The Potentials and Pitfalls Chapter 12

S. Badve, Rashmil Saxena, 2022 .

PUBLISHED VERSION

K. Klein, K. Polkinghorne, S. Paul, 2014 .

Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care

V. Perkovic, P. Ronksley, S. Badve, 2023, medRxiv.

The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

M. Jardine, V. Perkovic, S. Kotwal, 2023, medRxiv.

Reviving the Dead: DASL Expression Analysis from Paraffin

S. Badve, 2008 .

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

David W. Johnson, Marie E. Edwards, B. Erickson, 2018, BMJ Open.

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

C. Hawley, S. Badve, N. Toussaint, 2019, BMJ Open.

Outcomes of Acinetobacter Peritonitis in Peritoneal Dialysis Patients: A Multicenter Registry Analysis

David W. Johnson, K. Sud, C. Hawley, 2018, Peritoneal Dialysis International.

M. Ruospo, S. Palmer, V. Saglimbene, 2022, BMJ.

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

M. Landray, J. Chan, K. Mahaffey, 2023, Nature Medicine.

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

V. Perkovic, S. Badve, C. Lo, 2017, The Cochrane database of systematic reviews.

Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD)

A. Karaboyas, M. Sood, P. Tanuseputro, 2023, Canadian journal of kidney health and disease.

Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.

G. Knoll, K. Burns, S. Badve, 2008, American Society of Nephrology. Clinical Journal.

Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD

David W. Johnson, C. Hawley, S. Badve, 2021, Journal of the American Society of Nephrology : JASN.

EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS.

David W. Johnson, K. Sud, C. Hawley, 2017, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

E. Beller, A. Cass, P. Snelling, 2015, Peritoneal Dialysis International.

The rationale and design of the Beta‐blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

A. Garg, A. Tonkin, H. Krum, 2015, Nephrology.

Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.

V. Perkovic, S. Badve, B. Neuen, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)

E. Milanzi, S. Badve, E. Pascoe, 2023, PLoS ONE.

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.

David W. Johnson, C. Hawley, S. McDonald, 2011, Clinical journal of the American Society of Nephrology : CJASN.

A Randomized Controlled Trial of Intravenous or Oral Iron for Posttransplant Anemia in Kidney Transplantation

David W. Johnson, C. Hawley, S. Badve, 2012, Transplantation.